United States · FDA National Drug Code directory
Desonide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-423_9d27c98f-5df2-45c7-a479-a4a04128e6b6
- Product NDC
- 45802-423
- Form
- OINTMENT
- Composition / generic term
- Desonide
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- NDA
- Marketing start / end (source format)
- 20060822
- Source listing expiry
- 20261231
Source-listed ingredients
- DESONIDE — .5 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (45802-423-35) / 15 g in 1 TUBE · 45802-423-35
- 1 TUBE in 1 CARTON (45802-423-37) / 60 g in 1 TUBE · 45802-423-37
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →